Although normal plasma ammonium levels can be maintained in children with inborn errors of ureagenesis, these children are vulnerable to episodic hyperammonemia often resulting in coma and death. To treat such episodes, we designed a therapeutic protocol that included prompt recognition of hyperammonemia, therapy with intravenous sodium benzoate, sodium phenylacetate, and arginine, and nitrogen-free intravenous alimentation. Dialysis was performed if the hyperammonemia was unresponsive to drug therapy. Twelve episodes of hyperammonemia in seven children deficient in carbamyl phosphate synthetase, ornithine transcarbamylase, or argininosuccinic acid synthetase were treated; one patient died and the others recovered. In two patients measurement of the distribution of urinary nitrogen revealed that hippurate nitrogen and phenylacetylglutamine nitrogen together accounted for 60 per cent of "effective" urinary waste nitrogen. Successful therapy of episodic hyperammonemia plays an important part in the long-term management of disorders of the urea cycle.
This article has been cited by other articles:
Lien, J., Nyhan, W. L., Barshop, B. A.
(2007). Fatal Initial Adult-Onset Presentation of Urea Cycle Defect. Arch Neurol
64: 1777-1779
[Abstract][Full Text]
Clay, A. S., Hainline, B. E.
(2007). Hyperammonemia in the ICU. Chest
132: 1368-1378
[Abstract][Full Text]
Enns, G. M., Berry, S. A., Berry, G. T., Rhead, W. J., Brusilow, S. W., Hamosh, A.
(2007). Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle Disorders. NEJM
356: 2282-2292
[Abstract][Full Text]
Niemi, A.-K., Enns, G. M.
(2006). Pharmacology Review: Sodium Phenylacetate and Sodium Benzoate in the Treatment of Neonatal Hyperammonemia. NeoReviews
7: e486-e495
[Full Text]
Endo, F., Matsuura, T., Yanagita, K., Matsuda, I.
(2004). Clinical Manifestations of Inborn Errors of the Urea Cycle and Related Metabolic Disorders during Childhood. J. Nutr.
134: 1605S-1609S
[Abstract][Full Text]
Bauer, M., Hamm, A. C., Bonaus, M., Jacob, A., Jaekel, J., Schorle, H., Pankratz, M. J., Katzenberger, J. D.
(2004). Starvation response in mouse liver shows strong correlation with life-span-prolonging processes. Physiol. Genomics
17: 230-244
[Abstract][Full Text]
Chung, Y. L., Wang, A.-J., Yao, L.-F.
(2004). Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy. Molecular Cancer Therapeutics
3: 317-325
[Abstract][Full Text]
Carducci, M. A., Gilbert, J., Bowling, M. K., Noe, D., Eisenberger, M. A., Sinibaldi, V., Zabelina, Y., Chen, T.-l., Grochow, L. B., Donehower, R. C.
(2001). A Phase I Clinical and Pharmacological Evaluation of Sodium Phenylbutyrate on an 120-h Infusion Schedule. Clin. Cancer Res.
7: 3047-3055
[Abstract][Full Text]
Schwab, A. J., Tao, L., Yoshimura, T., Simard, A., Barker, F., Pang, K. S.
(2001). Hepatic uptake and metabolism of benzoate: a multiple indicator dilution, perfused rat liver study. Am. J. Physiol. Gastrointest. Liver Physiol.
280: G1124-G1136
[Abstract][Full Text]
Han, S., Wada, R. K., Sidell, N.
(2001). Differentiation of Human Neuroblastoma by Phenylacetate Is Mediated by Peroxisome Proliferator-activated Receptor {{gamma}}. Cancer Res.
61: 3998-4002
[Abstract][Full Text]
Wang, Q. M., Feinman, R., Kashanchi, F., Houghton, J. M., Studzinski, G. P., Harrison, L. E.
(2000). Changes in E2F Binding after Phenylbutyrate-induced Differentiation of Caco-2 Colon Cancer Cells. Clin. Cancer Res.
6: 2951-2958
[Abstract][Full Text]
Witzig, T. E., Timm, M., Stenson, M., Svingen, P. A., Kaufmann, S. H.
(2000). Induction of Apoptosis in Malignant B Cells by Phenylbutyrate or Phenylacetate in Combination with Chemotherapeutic Agents. Clin. Cancer Res.
6: 681-692
[Abstract][Full Text]
Kebebew, E., Wong, M. G., Siperstein, A. E., Duh, Q.-Y., Clark, O. H.
(1999). Phenylacetate Inhibits Growth and Vascular Endothelial Growth Factor Secretion in Human Thyroid Carcinoma Cells and Modulates Their Differentiated Function. J. Clin. Endocrinol. Metab.
84: 2840-2847
[Abstract][Full Text]
Lee, B., Dennis, J. A., Healy, P. J., Mull, B., Pastore, L., Yu, H., Aguilar-Cordova, E., O'Brien, W., Reeds, P., Beaudet, A. L.
(1999). Hepatocyte gene therapy in a large animal: A neonatal bovine model of citrullinemia. Proc. Natl. Acad. Sci. USA
96: 3981-3986
[Abstract][Full Text]
Chang, S. M., Kuhn, J. G., Robins, H. I., Schold, S. C., Spence, A. M., Berger, M. S., Mehta, M. P., Bozik, M. E., Pollack, I., Schiff, D., Gilbert, M., Rankin, C., Prados, M. D.
(1999). Phase II Study of Phenylacetate in Patients With Recurrent Malignant Glioma: A North American Brain Tumor Consortium Report. JCO
17: 984-984
[Abstract][Full Text]
Prasad, A. N., Breen, J. C., Ampola, M. G., Rosman, N. P.
(1997). Argininemia: A Treatable Genetic Cause of Progressive Spastic Diplegia Simulating Cerebral Palsy: Case Reports and Literature Review. J Child Neurol
12: 301-309
[Abstract]
Maestri, N. E., Brusilow, S. W., Clissold, D. B., Bassett, S. S.
(1996). Long-Term Treatment of Girls with Ornithine Transcarbamylase Deficiency. NEJM
335: 855-860
[Abstract][Full Text]
Burzynski, S.
(1993). Antineoplastons: The Controversy Continues. JAMA
269: 475-475
[Abstract]
CYR, D. M., TREMBLAY, G. C.
(1989). On Combination Therapy With Benzoate and Piridoxilate. Arch Pediatr Adolesc Med
143: 1392-1392
[Abstract]
Rowe, P. C., Valle, D., Brusilow, S. W.
(1988). Inborn Errors of Metabolism in Children Referred With Reye's Syndrome: A Changing Pattern. JAMA
260: 3167-3170
[Abstract]
Kang, H.-L., Benzer, S., Min, K.-T.
(2002). Life extension in Drosophila by feeding a drug. Proc. Natl. Acad. Sci. USA
99: 838-843
[Abstract][Full Text]
Lee, B., Yu, H., Jahoor, F., O'Brien, W., Beaudet, A. L., Reeds, P.
(2000). In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle. Proc. Natl. Acad. Sci. USA
97: 8021-8026
[Abstract][Full Text]
Previous
